It is shown that the PI3K/Akt/mTOR pathway is triggered in TNBC, and PI3K/Akt/mTOR pathway inhibitors can inhibit the tumor growth of TNBC and cause the apoptosis of cancer cells conversely (Costa et al. 2018; Massihnia et al. 2016). This evidence concerns the gene AKT1 and cancer.